November is still a long ways away and another scientific presentation isn't on the top of everyone's mind. However, I did notice that Resverlogix has a presentation at this year's American Heart Association meeting in Anaheim, CA on November 13th, 2017. Abstracts are still embargoed. Looks like Dr. Kulikowski will be presenting. This time focusing on vascular calcification. We've seen some of this data in past slide decks from investor presentations/corporate updates. If I'm not mistaken, this will be the first time they'll be presenting at a formal scientific meeting on this subject. 

http://www.abstractsonline.com/pp8/#!/4412/session/1813

M5084 / 5084 - Apabetalone Downregulates Factors That Promote Vascular Calcification and Contribute to Cardiovascular Events

American Society for Nephrology (ASN) Kidney week is also coming up at the beginning of November. Accepted abstracts will be posted by October 13th. With the pending start of the renal trial, it would be nice to see Resverlogix present here too.